On June 23, 2024, Novo Integrated Sciences, Inc. amended a securities purchase agreement with Streeterville Capital, LLC. The amendment, referred to as the First Amendment, modifies the original agreement made on April 5, 2024, where Novo Integrated Sciences issued a secured convertible promissory note to Streeterville with a principal sum of $6,210,000 and a maturity date of April 8, 2025. The First Amendment allows the registration statement for at least 3,500,000 shares of common stock for Streeterville to be filed on Form S-1 or S-3 by July 3, 2024. Additionally, Streeterville waived any potential breaches or defaults by Novo Integrated Sciences related to the timely filing of the Registration Statement as of June 23, 2024. This information was disclosed in a Current Report on Form 8-K filed with the SEC, which includes the full text of the First Amendment as Exhibit 10.1.

On June 23, 2024, Novo Integrated Sciences, Inc. amended a securities purchase agreement with Streeterville Capital, LLC. The amendment, referred to as the First Amendment, modifies the original agreement made on April 5, 2024, where Novo Integrated Sciences issued a secured convertible promissory note to Streeterville with a principal sum of $6,210,000 and a maturity date of April 8, 2025. The First Amendment allows the registration statement for at least 3,500,000 shares of common stock for Streeterville to be filed on Form S-1 or S-3 by July 3, 2024. Additionally, Streeterville waived any potential breaches or defaults by Novo Integrated Sciences related to the timely filing of the Registration Statement as of June 23, 2024. This information was disclosed in a Current Report on Form 8-K filed with the SEC, which includes the full text of the First Amendment as Exhibit 10.1.